Home
Conditions
Hepatocellular Carcinoma

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,013 public trials 264 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Recruiting

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

NCT04803318

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

NCT03198546

Conditions: Adenocarcinoma, CAR, Carcinoma, +15 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma

NCT04340986

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Serviec hépatologie-Hôpital Saint Antoine Paris, France

View Trial Details

Recruiting

Liver Cancer Disparities in American Indian and Alaska Native Persons

NCT05304234

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +23 more
Locations: Cherokee Nation Health Service Tahlequah, Oklahoma, United States

View Trial Details

Recruiting

ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery

NCT06204835

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Guangdong Guangzhou, Guangdong, China

Sichuan Luzhou, Sichuan, China

View Trial Details

Recruiting

Vienna Hypothermic Oxygenated Machine Perfusion Study

NCT06418165

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Medical University of Vienna Vienna, Austria

View Trial Details

Recruiting

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

NCT05866783

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Ghent University Hospital Ghent, Belgium

View Trial Details

Recruiting

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

NCT06406634

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

NCT06389422

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

NCT06363006

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH) Beijing, Beijing Municipality, China

View Trial Details

Hepatocellular Carcinoma

Hepatocellular Carcinoma trial results

Related conditions